# Corticosteroids in Hyperinflammatory Phenotype of Critical Illness

> **NCT07511582** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Bin Du** · enrollment: 150 (estimated)

## Conditions studied

- Sepsis
- Acute Respiratory Distress Syndrome

## Interventions

- **DRUG:** Methylprednisolone (MP)
- **DRUG:** Methylprednisolone (MP)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07511582
- **Lead sponsor:** Bin Du
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2028-04-01
- **Final completion:** 2028-04-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07511582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07511582, "Corticosteroids in Hyperinflammatory Phenotype of Critical Illness". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07511582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*